3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
4
Observational
1
Sponsor
Cancer Type
Sarcoma
17
CNS
5
Other solid neoplasm
3
Lymphoid
3
Genitourinary
3
Gastrointestinal
3
Other hematologic neoplasm
2
Gynecologic
2
Dermatologic
2
Breast
2
Thoracic
1
Head & Neck
1
Endocrine
1
Classical hematology
1
Conditions
Head and Neck Neoplasms
496
Squamous Cell Carcinoma of Head and Neck
226
Thyroid Neoplasms
222
Mouth Neoplasms
112
Nasopharyngeal Carcinoma
109
Thyroid Nodule
76
Oropharyngeal Neoplasms
74
Neoplasms
72
Lung Neoplasms
71
Breast Neoplasms
66
Laryngeal Neoplasms
61
Thyroid Cancer, Papillary
59
Salivary Gland Neoplasms
44
Prostatic Neoplasms
44
Thyroid Diseases
43
Carcinoma, Squamous Cell
43
Esophageal Neoplasms
42
Melanoma
39
Carcinoma, Non-Small-Cell Lung
34
Pancreatic Neoplasms
33
Nasopharyngeal Neoplasms
32
Colorectal Neoplasms
31
Uterine Cervical Neoplasms
30
Urinary Bladder Neoplasms
27
Stomach Neoplasms
27
Ovarian Neoplasms
25
Colonic Neoplasms
23
Hypopharyngeal Neoplasms
22
Parathyroid Neoplasms
21
Liver Neoplasms
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Rhabdomyosarcoma
×
Head & Neck
×
Clear all
NCT05697198
2025-03-06
PREFER
Labcorp Corporation of America Holdings, Inc
Completed
1,429 enrolled